Clinical trial
Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins
NCT00082355 · Richard Chang, M.D., NIH · Completed
Key facts
| NCT number | NCT00082355 |
|---|---|
| Title | Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins |
| Official title | The Treatment of Deep Vein Thrombosis (DVT) of the Lower Extremities With "Low-Dose" Alteplase: a Pilot Study |
| Lead sponsor | Richard Chang, M.D., NIH |
| Collaborators | National Institutes of Health Clinical Center (CC) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Deep Venous Thrombosis of the Lower Extremity |
| Intervention type | Drug |
| Interventions | Alteplase (Activase, Genentech) |
| Enrollment | 30 |
| Start date | May 1, 2004 |
| Primary completion | Mar 1, 2010 |
| Completion | Oct 1, 2014 |
| First posted | May 6, 2004 |
| Last update posted | Nov 6, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: